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OBJECTIVES: The aim of this study was to analyze silicone tubes with an internal diameter of 4 mm as a possible
material for vascular prostheses.
METHODS: Grafts were implanted into the infrarenal aortas of 33 rabbits. Fluoroscopic examinations were
performed within 150 days after surgical implantation. Sample grafts were analyzed via electron microscopy to
evaluate the eventual endothelialization of the prostheses.
RESULTS: The patency rates of the prostheses were 87% (±6.7%) after 30 days, 73% (±9.3%) after 60 days and
48% (±12%) after 120 days. The material presented characteristics that support surgical implantation: good
tolerance promoted by polyester tear reinforcement, ease of postoperative removal and a lack of pseudo-
aneurysms. However, intimal hyperplasia was a limiting factor for the patency rate.
CONCLUSIONS: We concluded that polydimethylsiloxane has limited potential as an alternative material for
small vascular prostheses.
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’ INTRODUCTION
Graft replacement of large vessels, such as the aorta and
the iliac and femoral arteries, is reasonably achieved using
currently available synthetic tubes, such as those composed
of polytetrafluoroethylene (PTFE) and Dacron (1-5). However, in
small vessels, none of these materials have proved to be superior
or equal to the saphenous vein (6-10), which is regarded as the
conduit of choice for peripheral revascularization (11-14).
A challenge that can arise is the lack of an available vein
for arterial replacement. A substantial amount of research
has been performed in this field, and there are several options
for solving this problem. Cryopreserved donor veins (15,16)
and biosynthetic materials are examples of alternatives
described in vascular surgery studies (17,18). However, the
search for an effective alternative for the replacement of small
vessels remains open (19,20).
Polydimethylsiloxane (PDMS), or silicone, has been used
in medicine since the 1960s (21,22). Due to its characteristics,
silicone has become one of the most frequently used materials
for prosthetic replacement in various contexts, such as breast
reconstruction (23). The use of PDMS in the form of various
types of catheters for the intravenous administration of sub-
stances is also widespread and universally accepted (24,25).
The characteristics that make this material attractive for
these uses are its excellent thermal stability, good wetting
properties, physiological inertness, excellent long-term biost-
ability and low thrombogenicity (26-28).
Given that the search for an ideal vascular prosthesis con-
tinues and that silicone is a material that promotes few tissue
reactions, this study aims to propose an experimental model
and test the hypothesis that PDMS is a suitable substitute for
small vessels.
’ MATERIALS AND METHODS
All surgical procedures were performed in domestic rabbits
(Oryctolagus cuniculus) in the Department of Surgery in the
Faculty of Medicine of the University of São Paulo. The
animals were provided by that institution’s animal house
and were cared for in accordance with principles established
by the Animal Welfare Act and the NIH Guide for Care and
Use of Laboratory Animals.
This study was conducted with the approval of the ethics
committee of the Faculty of Medicine of the University of
São Paulo.
A tubular prosthesis made ??of PDMS (silicone) reinforced
with polyester fabric was implanted into the infrarenal aorta
of each animal.DOI: 10.6061/clinics/2017(12)10
Copyright & 2017 CLINICS – This is an Open Access article distributed under the
terms of the Creative Commons License (http://creativecommons.org/licenses/by/
4.0/) which permits unrestricted use, distribution, and reproduction in any
medium or format, provided the original work is properly cited.
No potential conflict of interest was reported.
780
BASIC RESEARCH
Synthetic prosthesis
The prostheses were prepared in accordance with a patent-
registered design (29). Medical-grade silicone in liquid form
was mixed with a curing agent and applied over a metal
mandrel covered with a polyester fabric to increase the
silicone’s tear resistance. To achieve uniform curing, rota-
tional movement of the mandrel was maintained, initially at
room temperature and then in an oven to achieve a post-cure
temperature of 110oC for 30 minutes. The PDMS prosthesis
exhibited a tubular wall of 0.4 mm and an internal diameter of
4 mm (Figure 1). Despite attempts to create a porous tube, the
final product was nonporous, and the internal and external
surfaces were composed of silicone. The fabric material
remained inside the wall simply to provide reinforcement.
Anesthetic procedures
Animals were anesthetized with a mixture of ketamine
hydrochloride (35 mg/kg i.m. Ketalar 10%; Cristalia, São Paulo,
Brazil) and xylazine hydrochloride (5 mg/kg i.m. Rompum
2%; Bayer AG, Leverkusen, Germany). During the surgical
procedures, the animals received saline solution (0.9% sodium
chloride) through a 22G catheter cannulated in the marginal
ear vein.
Surgical technique
An anterior laparotomy was performed, and a transper-
itoneal approach allowed for the dissection of 3 to 4 cm of the
infrarenal aorta. A specifically developed self-static retractor
was used to avoid evisceration during this exposure. The
lumbar arteries were carefully preserved. Before the aorta
was clamped with microsurgical clamps, sodium heparin
(200 U/kg i.v.; Hepamax, Blausiegel, São Paulo, Brazil) was
administered.
Anastomoses of the PDMS in the aorta were completed
using an end-to-side technique and a continuous 7-0 poly-
propylene suture. At the end of the proximal anastomosis,
blood flow was released for a few minutes for ischemic
conditioning.
At the end of the vascular anastomosis, pulses were checked,
and the aorta was ligated with 4-0 cotton and cut between the
anastomotic sites.
The animals were evaluated for up to 150 days. All surviv-
ing animals were subjected to fluoroscopic examination via
retrograde femoral contrast injection.
Prosthesis evaluations
The prostheses were evaluated using aortic fluoroscopy.
Images were acquired on a Diasonics OECs 9000 fluoro-
scopy scanner (Salt Lake City, Utah, USA). Dissection of the
femoral artery was performed via unilateral inguinal incision
to perfuse the contrast agent diatrizoate meglumine (Reliev
60%; BerliMed S.A., São Paulo, Brazil).
At the end of the experimental procedures, the animals
were euthanized while they remained anesthetized with
19.1% potassium chloride (Isofarma, Eusébio, CE, Brazil),
and their bodies were disposed of in accordance with the
surgical department’s routine procedures.
The prostheses were removed after euthanasia, and
samples were sent for scanning electron microscopy; images
were obtained using a Philips XL30 system (FEI, Hillsboro,
Oregon, USA).
Statistical analysis
The Kaplan-Meier method was used to analyze risk of
occlusion and patent condition. Statistical analyses were
performed using SPSS 18.0 software.
’ RESULTS
Surgical procedures were performed in 64 animals. Thirty
animals (46.9%) survived until late evaluations. Early mor-
tality was observed in 23 animals (35.9%). Eleven animals
(17.2%) developed paraplegia in the immediate postopera-
tive period, and these animals were not considered for long-
term follow-up.
All 30 surviving animals were submitted to angiographic
control at the end of the observational period. In three para-
plegic animals that were not considered for late follow-up,
angiography was performed to diagnose the status of the
graft. Another three animals were excluded from late follow-
up because early occlusion (at less than 7 days) of the graft
was detected. The remaining 27 animals were analyzed using
Kaplan-Meier survival/patency curves.
Surgical characteristics
The walls of the prostheses had characteristics of flexibility
and hardness that allowed for easy passage of the needle and
retention and containment of the suture lines. Thus, satis-
factory hemostasis was achieved at the end of the experi-
ments, and the presence of a pulse distal to the anastomoses
attested to the immediate patency of the prostheses in all
animals.
Prosthesis evaluations
The patency rates of the prosthesis were 87% (±6.7%) after
thirty days, 73% (±9.3%) after sixty days, 57% (±11%) after
ninety days and 48% (±12%) after one hundred twenty days
(Figure 2). The risk of occlusion is indicated in Figure 3.
Macroscopic analysis
Peri-implant fibrous tissue was easy to identify, and a
cleavage plane between the periprosthetic tissue reaction and
the tube was observed. Neither aneurysmal dilatation of the
implant nor pseudoaneurysm formation in the suture lines
was observed. Inside the occluded grafts, whitish thrombi
Figure 1 - PDMS prosthesis with a tubular wall of 0.4 mm and an internal diameter of 4 mm.
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vwere observed that were likely caused by intimal hyper-
plasia, which was subsequently confirmed via scanning
electron microscopy.
Scanning electron microscopy
Electron microscopy was used to provide additional infor-
mation in this study. It was possible to observe endothelial
growth from the native vessel toward the PDMS graft, a
finding consistent with intimal hyperplasia (Figure 4).
’ DISCUSSION
Vascular prostheses have been used for several decades to
restore blood flow at many sites. However, although the
functions of such prostheses have been well established for
large vessels, the use of these prostheses is greatly limited in
vessels with a diameter of less than four millimeters (9).
This study demonstrated that the patency rate for PDMS
prostheses after ninety days was 57% (±11%). Nordestgaard
et al. (30) performed a similar study but used ePTFE pros-
theses with a diameter of three millimeters that were also
implanted into rabbit aortas. Those authors reported a patency
rate of 82% after ninety days. In 2012, Zheng et al. (31) tested
polycaprolactone prostheses coated with arginine-glycine-
aspartic acid in the carotid arteries of ten rabbits, and the
patency rate after four weeks was 100%. However, the
authors discussed their short observation period and acknowl-
edged that one month is not sufficient for vascular regenera-
tion. If we considered only thirty days of follow-up, then
we would have observed 87% patency (±6.7%) in our
experiments.
Intimal hyperplasia is the result of natural cicatrization
after vascular injuries, especially in anastomotic regions, and
is a major cause of vascular stenosis and occlusions (32).
Anastomotic intimal hyperplasia is more likely to develop
for synthetic prostheses than for vein grafts. Given that the
endothelium is responsible for preservation of the intravas-
cular structure (33,34), it is natural to search for graft
endothelialization. One method for achieving endothelial
growth relates to graft porosity. The porosity concept for
vascular grafts and the growth of endothelial cells that could
pave the inner surface of such grafts remain controversial in
medical science.
Theoretically, pores are scaffolds for the passage and
habitation of vascular cells through the graft lumen. Thus, it
was thought that larger spaces between graft nodes would
correspond to greater cell housing (35). However, intermedi-
ate porosity is considered to be more suitable for preventing
intimal hyperplasia (36). In contrast, Lumsden et al. (37)
achieved satisfactory results from coating PTFE prostheses
with non-porous silicone to promote a smooth and uniform
surface and limit internal tissue growth beyond the trans-
anastomotic region. Based on that study, we developed an
Figure 4 - Electron microscopy image showing endothelial growth
from the native vessel toward the PDMS graft, which is consistent
with intimal hyperplasia.
Figure 2 - Proportion of "survivors" in the patent condition.
The patency rates of the prosthesis were 87% (±6.7%) after
thirty days, 73% (±9.3%) after sixty days, 57% (±11%) after
ninety days and 48% (±12%) after one hundred twenty days.
Figure 3 - Risk of occlusion of the prosthesis.
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experimental model to test the hypothesis that non-porous
silicone could be a suitable prosthesis material for small
vessels. We believe that our patency results are consistent
with the development of intimal hyperplasia in the anasto-
motic region. Electron microscopy generated images compa-
tible with endothelial growth from the anastomotic region.
Further studies with porous silicone could demonstrate
the difference between porous and non-porous grafts and
elucidate the cause of intimal cell growth in synthetic
prostheses.
In evaluations of prostheses, patency has always been
demonstrated via contrast injection into the aorta (using
arteriography performed via retrograde catheterization) and
long-term monitoring. Occlusions that occur in less than
thirty days are related to surgical failures, such as technical
failures with respect to anastomosis, prosthesis placement,
prosthesis folding or insufficient blood flow (38). In our study,
we performed prosthesis evaluation for up to 150 days.
Within this period, we aimed to perform arteriography as late
as possible.
The use of polyester as reinforcement for the PDMS was
intended to prevent tears during prosthesis suturing because
PDMS has a low tear tolerance. This coating appeared to be
useful because these events did not occur during any surgical
procedure. Moreover, pseudoaneurysms were not observed.
Although the silicone graft did not show satisfactory results
with respect to long-term patency, the use of this material
in other forms, such as sheets, has already been tested.
An experimental study that used the same animal model
produced extremely good results for patches in the aortas of
rabbits (39).
The tested material exhibited characteristics that support
surgical implantation: good tolerance promoted by polyester
tear reinforcement, ease of postoperative removal and lack
of pseudoaneurysms. However, intimal hyperplasia was a
limiting factor for the patency rate. We concluded that
PDMS has limited potential as an alternative small vascular
prosthesis material.
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